TrialAnnals of the American Thoracic Society2023

Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity.

Anne E Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.